Find a vein specialist doctor 

Varicose Vein disease appears to have a genetic predisposition and is estimated to affect almost 60% of all adult Americans with a cumulative risk over time. Current estimates indicate that almost 2.8 million persons, 1% of the US population, suffer from complications of prolonged venous reflux. Studies show that 41% of American women may have varicose vein disease by the fourth to fifth decade of life. The risk increases to 72% in their seventh decade (4). Greater saphenous vein (GSV) varicosities with or without saphenofemoral incompetence (SFI) are the primary problem in almost 20-50% of patients who suffer from varicose vein disease, while telangiectatic or medium veins will be involved in 50-80% of such patients.

For the last three decades studies have demonstrated the morbid presentations of varicose vein disease to significantly affect the overall quality of a patient's life. Moreover, it may lead to life-threatening conditions such as thrombophlebitis, thromboembolism, hemorrhage and deep venous thrombosis, and thus requires timely management (3-7).